Benzinga
24 Sept 2026, 09:05 UTC · 6w ago
Impact · against what's priced in
GlucoTrack's shares are reacting to the establishment of a non-dilutive revenue stream via Lokahi Therapeutics' first external fee-for-service partnership. Other mentioned tickers are seeing price volatility without specific fundamental catalysts provided in the text.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish · 2 new · 0 priced in
GlucoTrack subsidiary Lokahi Therapeutics signed its first external, fee-for-service partnership with nonprofit Innovate GBM.
Newannouncement reported September 24, 2026
So whatEstablishing a fee-for-service model creates a non-dilutive revenue stream to offset R&D burn in upcoming quarters.
More positive than 93% of claims this week
Continue reading
5 related stories
The partnership between Lokahi Therapeutics and Innovate GBM introduces a fee-for-service revenue model to offset R&D burn, which is a material shift in the company's funding profile.
Read from the article alone
No priced-in read yet
Shares are trading down significantly by 29.8% in pre-market trading without a specified fundamental driver in the report.
Read from the article alone
No priced-in read yet
Shares are trading down significantly by 34.8% in pre-market trading without a specified fundamental driver in the report.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
GlucoTrack shares rose 117.7% to $4.42 in pre-market trading.
Newreported pre-market September 24, 2026
So whatThe spike to $4.42 significantly alters the float valuation and may trigger short-covering within the session.
More positive than 62% of claims this week
Which stocks this story touches
More negative than 99% of ticker scores this week
Shares are trading down significantly (-34.8%) in pre-market trading.
More positive than 98% of ticker scores this week
Shares jumped over 117% following the announcement of a new fee-for-service partnership via its subsidiary.
More negative than 97% of ticker scores this week
Shares are trading down significantly (-29.8%) in pre-market trading.
More negative than 97% of ticker scores this week
Shares are trading down significantly (-16.7%) in pre-market trading.
More negative than 97% of ticker scores this week
Shares are trading down significantly (-23.5%) in pre-market trading.
More positive than 87% of ticker scores this week
Shares are trading up significantly (18.1%) in pre-market trading.
More negative than 93% of ticker scores this week
Shares are trading down significantly (-8.45%) in pre-market trading.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
MarketBeat
1h ago
—
No price for BENF right now — the quote feed didn't answer.
BENF chart →—
No price for ARTL right now — the quote feed didn't answer.
ARTL chart →—
No price for GCTK right now — the quote feed didn't answer.
GCTK chart →
